BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9613987)

  • 1. BCL-2 immunohistochemical evaluation in B-cell chronic lymphocytic leukemia and hairy cell leukemia before treatment with fludarabine and 2-chloro-deoxy-adenosine.
    Zaja F; Di Loreto C; Amoroso V; Salmaso F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Mariuzzi L; Beltrami CA; Baccarani M
    Leuk Lymphoma; 1998 Feb; 28(5-6):567-72. PubMed ID: 9613987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
    Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
    [No Abstract]   [Full Text] [Related]  

  • 3. New purine analogues for the treatment of chronic B-cell malignancies.
    Gribbin TE
    Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of 2-chloro-2'-deoxyadenosine in chronic lymphocytic leukemia, hairy cell leukemia, and autoimmune hemolytic anemia.
    Carson DA; Piro LD; Wasson DB; Carrera CJ; Beutler E
    Adv Exp Med Biol; 1989; 253A():427-31. PubMed ID: 2576181
    [No Abstract]   [Full Text] [Related]  

  • 5. Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
    Larsen CR; Hansen PB; Clausen NT
    Am J Hematol; 2002 May; 70(1):48-50. PubMed ID: 11994981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairy cell leukemia. What is new forty years after the first description?
    Troussard X; Maloisel F; Flandrin G
    Hematol Cell Ther; 1998 Aug; 40(4):139-48. PubMed ID: 9766918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
    Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to 2-chlorodeoxyadenosine in patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Juliusson G; Elmhorn-Rosenborg A; Liliemark J
    N Engl J Med; 1992 Oct; 327(15):1056-61. PubMed ID: 1355853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutively Photomorphogenic 1 Reduces the Sensitivity of Chronic Lymphocytic Leukemia Cells to Fludarabine Through Promotion of Ubiquitin-Mediated P53 Degradation.
    Fu C; Shi X; Gong Y; Wan Y; Sun Z; Shi H; Wang Z; Marinaccio C; Crispino JD; Xu K
    Cell Physiol Biochem; 2018; 50(6):2314-2328. PubMed ID: 30423551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous diagnosis of hairy cell leukemia and chronic lymphocytic leukemia/small lymphocytic lymphoma: a frequent association?
    Giné E; Bosch F; Villamor N; Rozman M; Colomer D; López-Guillermo A; Campo E; Montserrat E
    Leukemia; 2002 Aug; 16(8):1454-9. PubMed ID: 12145685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues.
    Witzig TE; Weitz JJ; Lundberg JH; Tefferi A
    Leuk Lymphoma; 1994 Jun; 14(1-2):137-9. PubMed ID: 7920220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features.
    Obiorah IE; Francischetti IMB; Wang HW; Ahn IE; Wang W; Raffeld M; Kreitman RJ; Wiestner A; Calvo KR
    Leuk Lymphoma; 2020 Dec; 61(13):3177-3187. PubMed ID: 32755330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 14. 2-CdA in the treatment of hairy cell leukaemia.
    Abhyankar D; Bajpai S; Saikia T; Gopal R; Nair CN; Advani SH
    J Assoc Physicians India; 2001 Aug; 49():785-7. PubMed ID: 11837464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
    Pott-Hoeck C; Hiddemann W
    Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
    Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
    J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purine analogs--a therapeutic beauty contest.
    Cheson BD
    J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
    [No Abstract]   [Full Text] [Related]  

  • 19. Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.
    Piro LD; Carrera CJ; Carson DA; Beutler E
    N Engl J Med; 1990 Apr; 322(16):1117-21. PubMed ID: 1969613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 protein expression and p53 gene mutation in chronic lymphocytic leukemia: correlation with in vitro sensitivity to chlorambucil and purine analogs.
    Morabito F; Filangeri M; Callea I; Sculli G; Callea V; Fracchiolla NS; Neri A; Brugiatelli M
    Haematologica; 1997; 82(1):16-20. PubMed ID: 9107076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.